Please ensure Javascript is enabled for purposes of website accessibility

Cowen Downgrades 3 Canadian Cannabis Stocks

By Cory Renauer – Feb 24, 2020 at 2:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the banks that's most enthusiastic about the marijuana industry just cut its ratings on some of the largest producers in North America.

One of the most enthusiastic analyst teams covering the cannabis sector just dialed back some of its assumptions about the state of retail cannabis sales in Canada. On Feb. 24, Vivien Azer, the top marijuana stock analyst at Cowen, lowered the investment bank's ratings for majors Aurora Cannabis (ACB -3.12%) and Tilray (TLRY), and the much-smaller Sundial Growers, from outperform to market perform.

Top analyst?

Despite disappointing sales during the first few months that adult-use recreational marijuana was fully legal in Canada, in January 2019, Azer told investors Canadian sales would probably reach CA$3.1 billion that year.

Small amount of marijuana and cash money.

Image source: Getty Images.

A few months later, Azer was especially enthusiastic about the roads ahead of Aurora Cannabis, Tilray, and Canopy Growth (CGC -2.23%). She still maintains an outperform rating on Canopy Growth, but you might want to look for a second opinion before purchasing any of these stocks.

Health Canada's commercial ineptitude has caught Azer by surprise at least once already. During the 12 months that ended September 2019 -- the first full-year period in which Canada allowed people to buy marijuana without a prescription -- retail sales of recreational marijuana reached just CA$908 million.

Looking ahead

In 2020, Azer thinks sales of recreational plus medical cannabis will climb to a combined CA$3.5 billion, or around 13% more than she had predicted for recreational sales a year earlier.

Even if she's correct, Aurora Cannabis, Tilray, Sundial, Canopy Growth, and more than a hundred other licensed producers will be trying to divide that CA$3.5 billion pie into enough slices to feed everyone. Those four companies alone have a combined market cap of around CA$14.36 billion. Betting on their shares to perform in line with the broad market -- or better in the case of Canopy Growth -- seems like a risky position to take right now.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Inc. Stock Quote
Aurora Cannabis Inc.
$1.24 (-3.12%) $0.04
Tilray, Inc. Stock Quote
Tilray, Inc.
Canopy Growth Corp. Stock Quote
Canopy Growth Corp.
$3.07 (-2.23%) $0.07
SNDL Inc.  Stock Quote
$2.26 (-1.74%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.